Prevention of Glomerular Dysfunction in Diabetic Rats by Treatment with d-α-Tocopherol

Journal of the American Society of Nephrology

Volumn 8, Issue 3, 1997, Pages 426-435

  Koya, Daisuke ^a   Lee, In Kyu ^a   Ishii, Hidehiro ^a   Kanoh, Hideo ^b   King, George L ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DIACYLGLYCEROL; DIACYLGLYCEROL KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C;

ALBUMINURIA; ANIMAL; ARTICLE; BLOOD; DIABETIC NEPHROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; HEMODYNAMICS; KIDNEY; KIDNEY CIRCULATION; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ALBUMINURIA; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIACYLGLYCEROL KINASE; DIGLYCERIDES; HEMODYNAMIC PROCESSES; KIDNEY; KIDNEY GLOMERULUS; MALE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; VITAMIN E;

EID: 0031093983     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Mogensen CE: Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Lab Invest 28: 91-100, 1971
2. Christiansen JS, Gammelgaard J, Frandsen M, Parving H-H: Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 20: 451-456, 1981
3. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981
4. Jensen PK, Christiansen JS, Steven K, Parving H-H: Renal function in streptozotocin-diabetic rats. Diabetologia 21: 409-414, 1981
5. Ishii H, Jirousek MR, Koya D, Takagi T, Xia P, Clermont A, Burscll S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272: 728-731, 1996
6. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89-93, 1984
7. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-360, 1984
8. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephrophathy in insulin-dependent diabetes mellitus. Lancet I: 1430-1432, 1982
9. Anderson S, Brenner BM: Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations. Diabetes Metab Rev 4: 163-177, 1988
10. DeRubertis FR, Craven PA: Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic nephropathy. Diabetes 43: 1-8, 1994
11. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes 44: 1139-1146, 1995
12. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Enden MVD, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813, 1993
13. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988
14. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
15. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
16. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89: 11059-11063, 1992
17. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL: Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265: E783-E793, 1993
18. Kunisaki M, Bursell SE, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL : Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269: E239-E246, 1995
19. Kunisaki M, Bursell SE, Umeda F, Nawata H, King GL: Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43: 1372-1377, 1995
20. Kreisberg JI, Ayo SH: The glomerular mesangium in diabetes mellitus. Kidney Int 43: 109-113, 1993
21. Kreisberg JI: Hyperglycemia and microangiopathy: Direct regulation by glucose of microvascular cells. Lab Invest 67: 416-426, 1992
22. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43: 1122-1129, 1994
23. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from storeptozotocin diabetic rats: Possible mediation by glucose. J Clin Invest 83: 1667-1675, 1989
24. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261: F571-F577, 1991
25. Williams B, Schrier RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41: 1464-1472, 1992
26. Kikkawa R, Haneda M, Uzu T, Koya D, Sugimoto T, Shigeta Y: Translocation of protein kinase C α and ζ in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 37: 838-841, 1994
27. Williams B, Schrier RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92: 2889-2896, 1993
28. Guzman NJ, Kurian P, Andaloro VJ, Tisher CC, Grews FT: Effect of glucose on receptor-mediated phosphoinositide hydrolysis and second messenger generation in rat glomerular mesangial cells. J Am Soc Nephrol 2: 179-190, 1992
29. Nishizuka Y: The family of protein kinase C for signal transduction. JAMA 262: 1826-1833, 1989
30. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992
31. Tasinato A, Boscoboinik D, Bartoli G-M, Maroni P, Azzi A: d-α-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci USA 92: 12190-12194, 1995
32. Kanoh H, Yamada K, Sakane F: Diacylglycerol kinase: A key modulator of signal transduction. Trends Biochem Sci 15: 47-50, 1990
33. Ueda T, Igarashi O: New solvent system for extraction of tocopherols from biological specimens for HPLC determination and the evaluation of 2, 2, 5, 7, 8-pentamethyl-6-chromanol as an internal standard. J Micronutr Anal 3: 185-198, 1987
34. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959
35. Preiss JE, Loomis CR, Bell RM, Niedel JE: Quantitative measurement of sn-1,2-diacylglycerols. Methods Enzymol 141: 294-300, 1984
36. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
37. Heasley LE, Johnson GL: Regulation of protein kinase C by nerve growth factor, epidermal growth factor, and phorbol esters in PC 12 pheochromocytoma cells. J Biol Chem 264: 8646-8652, 1989
38. Yasuda I, Kishimoto A, Tanaka S-I, Tominaga M, Sakurai A, Nishizuka Y: A synthetic peptide substrate for selectivity assay of protein kinase C. Biochem Biophys Res Commun 166: 1220-1227, 1990
39. Sakane F, Yamada K, Imai S-I, Kanoh H: Porcine 80-kDa diacylglycerol kinase is a calcium-binding and calcium/phospholipid-dependent enzyme and undergoes calcium-dependent translocation. J Biol Chem 266: 7096-7100, 1991
40. Goto K, Watanabe M, Kondo H, Yuasa H, Sakane F, Kanoh H: Gene cloning, sequence, expression and in situ localization of 80 kDa diacylglycerol kinase specific to oligodendrocyte of rat brain. Brain Res Mol Brain Res 16: 75-87, 1992
41. Kai M, Sakane F, Imai S-I, Wada I, Kanoh H: Molecular cloning of a diacylglycerol kinase isozyme predominantly expressed in human retina with a truncated and inactive enzyme expression in most other human cells. J Biol Chem 269: 18492-18498, 1994
42. Waugh WH: Photometry of inulin and polyfructosan by use of a cysteine/tryptophan reaction. Clin Chem 23: 639-645, 1977
43. Dalton RN, Wiseman MJ, Turner C, Viberti G: Measurement of urinary para-aminohippuric acid in glycosuric diabetics. Kidney Int 34: 117-120, 1988
44. Engerman R, Bloodworth JM Jr, Nelson S: Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760-769, 1977
45. Cohen AJ, McGill PD, Rossetti RG, Guberski DL, Like AA: Glomerulopathy in spontaneously diabetic rat: Impact of glycemic control. Diabetes 36: 944-951, 1987
46. Craven PA, Davidson CM, DeRubertis FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39: 667-674, 1990
47. Inoguchi T, Xia P, Kunisaki M, Higashi S, King GL: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 267: E369-E379, 1994
48. Bell RM: Protein kinase C activation by diacylglycerol second messengers. Cell 45: 631-632, 1986
49. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats: Evidence for protein kinase C-mediated suppression of the cholinergic response. J Clin Invest 93: 311-320, 1994
50. Studer RK, Craven PA, DeRubertis FR: Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 42: 118-126, 1993
51. Tran K, Proulx PR, Chan AC: Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DAG kinase activity. Biochem Biophys Acta 1212: 193-202, 1994
52. Sakane F, Imai S-I, Kai M, Wada I, Kanoh H: Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases. J Biol Chem 271: 8394-8401, 1996
53. Bunting M, Tang W, Zimmerman GA, McIntyre TM, Prescott SM: Molecular cloning and characterization of a novel human diacylglycerol kinase ζ. J Biol Chem 271: 10230-10236, 1996
54. Tang W, Bunting M, Zimmerman GA, McIntyre TM, Prescott SM: Molecular cloning of a novel human diacylglycerol kinase highly selective for arachidonate-containing substrates. J Biol Chem 271: 10237-10241, 1996
55. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH, Fu MX, Baynes J: Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am J Physiol 269: F429-F438, 1995
56. Meyers DG, Maloley PA, Weeks D: Safety of antioxidant vitamins. Arch Intern Med 156: 925-935, 1996
57. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781-786, 1996
58. Urano S, Yano K and Matsuo M: Membrane-stabilizing effect of vitamin E: Effect of α-tocopherol and its model compounds on fluidity of lecithin liposomes. Biochem Biophys Res Commun 150: 469-475, 1988
59. +-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 96: 733-740, 1995
60. Ortola FV, Ballermann BJ, Anderson S, Mendez RE, Brenner BM: Elevated plasma atrial natriuretic peptide levels in diabetic rats: Potential mediator of hyperfiltration. J Clin Invest 80: 670-674, 1987
61. Sakamoto K, Kikkawa R, Haneda M, Shigeta Y: Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist. Diabetologia 38: 536-542, 1995
62. Suzuki E, Hirata Y, Kohmoto O, Sugimoto T, Hayakawa H, Matsuoka H, Sugimoto T, Kojima M, Kangawa K, Minamino N, Matsuo H: Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ Res 71:1039-1048, 1992